Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
about
Glioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and RadioresistanceThe niche under siege: novel targets for metastasis therapyThe wound healing, chronic fibrosis, and cancer progression triadSubventricular zone involvement in Glioblastoma - A proteomic evaluation and clinicoradiological correlationTenascin-W is a specific marker of glioma-associated blood vessels and stimulates angiogenesis in vitro.Notch signaling in glioblastoma: a developmental drug target?Tenascin-C enhances pancreatic cancer cell growth and motility and affects cell adhesion through activation of the integrin pathwayA multigene predictor of outcome in glioblastoma.Tenascins and the importance of adhesion modulation.Tenascin-C: a novel candidate marker for cancer stem cells in glioblastoma identified by tissue microarraysAdvances in tenascin-C biology.ADAM-9 is a novel mediator of tenascin-C-stimulated invasiveness of brain tumor-initiating cells.Printed peptide arrays identify prognostic TNC serumantibodies in glioblastoma patients.Molecular biology of human gliomas.Glioma-specific antigens for immune tumor therapy.Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.Laminin alpha 2 enables glioblastoma stem cell growthEmerging monoclonal antibody therapies for malignant gliomas.Gliomatosis cerebri: growing evidence for diffuse gliomas with wide invasion.Glioma Stem Cells but Not Bulk Glioma Cells Upregulate IL-6 Secretion in Microglia/Brain Macrophages via Toll-like Receptor 4 Signaling.PET imaging of tenascin-C with a radiolabeled single-stranded DNA aptamer.mTOR signal transduction pathways contribute to TN-C FNIII A1 overexpression by mechanical stress in osteosarcoma cellsPassive immunotherapeutic strategies for the treatment of malignant gliomas.Radioresistance of glioma stem cells: intrinsic characteristic or property of the 'microenvironment-stem cell unit'?Modulation of Tumor Cell Survival, Proliferation, and Differentiation by the Peptide Derived from Tenascin-C: Implication of β1-Integrin Activation.Radioimmunotherapy for high-grade glioma.Systematic review of protein biomarkers of invasive behavior in glioblastoma.Notching on Cancer's Door: Notch Signaling in Brain Tumors.Role of tenascins in the ECM of gliomas.MicroRNA-107 inhibits glioma cell migration and invasion by modulating Notch2 expression.Brevican, neurocan, tenascin-C and versican are mainly responsible for the invasiveness of low-grade astrocytoma.Apoptotic death of hematopoietic tumor cells through potentiated and sustained adhesion to fibronectin via VLA-4Regulatory effect of nerve growth factor in alpha9beta1 integrin-dependent progression of glioblastoma.RNF13: a novel RING-type ubiquitin ligase over-expressed in pancreatic cancer.Distribution of myofibroblast and tenascin-C in cystic adventitial disease: comparison with ganglion.Tenascin-C Is Associated with Cored Amyloid-β Plaques in Alzheimer Disease and Pathology Burdened Cognitively Normal Elderly.Glioblastoma Stem Cells and Their Microenvironment.Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups.Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas.Brain tumor-initiating cells export tenascin-C associated with exosomes to suppress T cell activity
P2860
Q26765869-11219216-77D9-40A7-9270-387D0472D31AQ26849444-2A87000B-D716-4210-A391-41459B111CB0Q27014616-116A3D4F-BB4A-48A8-8FEA-68D68D11569AQ33684168-4FA326D7-A966-4FAC-9737-DDB50E2052D6Q33694568-9FA22E05-4DDF-4CBD-83B7-B079E636F4E0Q33747041-ABB28CB8-C96B-41DE-83EC-119CFB816CE5Q33957943-3BD8092E-CE57-4809-8E95-4431DB56BD02Q34132666-A7924031-FD08-411E-A464-96124CD264C2Q35006502-BD7B9E12-BC48-4DE1-B0CF-E69F19F1DCFAQ35060849-0D71C20E-A3C9-4705-9D81-C63F08C82894Q35214557-34D74673-2739-40DB-86F8-D35C8FD41EC3Q35815285-1ABA18AC-0DC5-4F6D-A87C-BB3B5F9A9308Q35955393-7C74BD1B-0251-4888-B880-395DE27BB353Q36478640-E574B834-A67B-4A31-B88D-88EDEB2E3DD9Q36690281-F5144D30-1E9B-48EF-B7EB-5D5693E41450Q36705901-F5CB792B-A2AA-445F-AA55-7F37A6D126FFQ36737141-F418C6DA-E47B-46BE-B218-A67545DA1431Q36764016-BEDA25F9-2586-4E2D-8552-BBEF633FD048Q37139776-EBB6F01C-CB45-42FB-AC5A-0D2774721834Q37228242-15662901-1B91-49D5-8D8C-F6E84062A9FFQ37580078-6C7C5F56-4C7F-4AA9-BCE6-5F536535114BQ37604821-F4FB70B5-E5B0-4D4B-A75B-5A9D3F45A99DQ37714783-2BCF0E43-BB5D-4590-A1CB-6D75F553C640Q37887286-BFBDDA0F-8254-4B62-81A4-7E7E46147DD2Q37973062-BFB68712-768E-4390-B5EF-28DE4D6F9526Q38110937-5AC37951-47F7-4A58-B272-87BFD1599EA1Q38165795-7DDEB638-78DD-4347-B66C-0C5911B6122BQ38324552-2D62440E-A702-4758-B358-250CF67A812FQ38361238-6EABDD9B-4DD7-40F8-8046-FE71F2A9AAB6Q39214165-7324C5F3-9AEA-48FB-81D3-EA84EED78DF4Q39697732-E3B00F08-8809-4E8B-BECD-CABD96200C62Q39761913-5F69C122-AFD8-4E02-8802-0FAC54AAE03FQ39905965-54C838DC-5A66-467B-8103-F9C662A6C9D3Q39939362-C8CF00F3-4140-4CB7-B70A-5D4D3B913EC3Q43941861-6F6EC042-A866-4774-8E2A-8E1FAC89D31AQ46633367-4CA57BB9-715E-4B56-AB64-FA0A70A981D5Q50076163-EA2A236F-0CB2-4375-8497-4DB59BCE9E10Q50218828-39756F50-77FA-46A5-867B-2DDCAE5F5DEBQ55467629-27457250-340A-487E-B803-09CFF78F1A1CQ57135138-D67DA6F4-D336-4F51-90CA-60D85934628F
P2860
Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Expression of tenascin-C in va ...... in patients with astrocytoma.
@en
Expression of tenascin-C in va ...... in patients with astrocytoma.
@nl
type
label
Expression of tenascin-C in va ...... in patients with astrocytoma.
@en
Expression of tenascin-C in va ...... in patients with astrocytoma.
@nl
prefLabel
Expression of tenascin-C in va ...... in patients with astrocytoma.
@en
Expression of tenascin-C in va ...... in patients with astrocytoma.
@nl
P2093
P356
P1433
P1476
Expression of tenascin-C in va ...... in patients with astrocytoma.
@en
P2093
Alexander Leins
Michail S Davidoff
Parviz Mehraein
Pietro Riva
Ragnar Lindstedt
Serge Weis
P304
P356
10.1002/CNCR.11796
P407
P577
2003-12-01T00:00:00Z